Myocardial tissue engineering: The quest for the ideal myocardial substitute

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 8, 2009, Pages 921-928

  Martinez, Eliana C ^a   Kofidis, Theo ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

Heart failure; Myocardial ischemia; Myocardial restoration; Stem cell; Tissue engineering

Indexed keywords

BIOMATERIAL; GLYCOSAMINOGLYCAN; VASCULOTROPIN; VON WILLEBRAND FACTOR; TISSUE SCAFFOLD;

BIOCOMPATIBILITY; BIODEGRADABILITY; CELL DIFFERENTIATION; CELL MATURATION; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBROBLAST; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOGENICITY; IMPLANTATION; NONHUMAN; REVIEW; THREE DIMENSIONAL IMAGING; TISSUE ENGINEERING; UPREGULATION; ANIMAL; BIOLOGICAL THERAPY; HEART DISEASE; METABOLISM; METHODOLOGY; PATHOLOGY;

ANIMALS; HEART DISEASES; HUMANS; MYOCARDIUM; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TISSUE THERAPY;

EID: 70350442815     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.81     Document Type: Review

References (54)

1. Braunwald E. Shattuck lecture - cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N. Engl. J. Med. 337(19), 1360-1369 (1997). (Pubitemid 27467771)
2. Koerner MM, Durand JB, Lafuente JA, Noon GP, Torre-Amione G. Cardiac transplantation: the final therapeutic option for the treatment of heart failure. Curr. Opin. Cardiol. 15(3), 178-182 (2000). (Pubitemid 30326640)
3. Gardner RS, McDonagh TA. The treatment of chronic heart failure due to left ventricular systolic dysfunction. Clin. Med. 4(1), 18-22 (2004).
4. Hosenpud JD, Bennett LE, Keck BM, Boucek MM, Novick RJ. The Registry of the International Society for Heart and Lung Transplantation: seventeenth official report-2000. J. Heart Lung Transplant. 19(10), 909-931 (2000).
5. Hunt SA. Current status of cardiac transplantation. JAMA 280(19), 1692-1698 (1998).
6. Zimmermann WH, Eschenhagen T. Embryonic stem cells for cardiac muscle engineering. Trends Cardiovasc. Med. 17(4), 134-140 (2007). (Pubitemid 46670024)
7. Kofidis T, de Bruin JL, Hoyt G et al. Myocardial restoration with embryonic stem cell bioartificial tissue transplantation. J. Heart Lung Transplant. 24(6), 737-744 (2005). (Pubitemid 40798258)
8. Fukuda K, Yuasa S. Stem cells as a source of regenerative cardiomyocytes. Circ. Res. 98(8), 1002-1013 (2006). (Pubitemid 43755221)
9. Kehat I, Gepstein L. Human embryonic stem cells for myocardial regeneration. Heart Fail. Rev. 8(3), 229-236 (2003). (Pubitemid 36992436)
10. Muller-Ehmsen J, Whittaker P, Kloner RA et al. Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol. 34(2), 107-116 (2002). (Pubitemid 35229976)
11. Vacanti CA. The history of tissue engineering. J. Cell. Mol. Med. 10(3), 569-576 (2006).
12. Lalan S, Pomerantseva I, Vacanti JP. Tissue engineering and its potential impact on surgery. World J. Surg. 25(11), 1458-1466 (2001). (Pubitemid 33108536)
13. Kofidis T, Lee CN. From vision to mission in myocardial restoration. Asian Cardiovasc. Thorac. Ann. 16(2), 91-92 (2008).
14. Buckberg GD. Basic science review: the helix and the heart. J. Thorac. Cardiovasc. Surg. 124(5), 863-883 (2002). •• Reviews the complex helical fiber distribution of the heart and its changes during heart failure.
15. Frangogiannis NG. The immune system and cardiac repair. Pharmacol. Res. 58(2), 88-111 (2008).
16. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81(4), 1161-1172 (1990). (Pubitemid 20119612)
17. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 76(1), 44-51 (1987).
18. Zimmermann WH. Remuscularizing failing hearts with tissue engineered myocardium. Antioxid. Redox Signal. 11(8), 2011-2023 (2009).
19. Caspi O, Lesman A, Basevitch Y et al. Tissue engineering of vascularized cardiac muscle from human embryonic stem cells. Circ. Res. 100(2), 263-272 (2007). • Reports the first engineered 3D human cardiac tissue based on human embryonic stem cells. (Pubitemid 46208727)
20. Birla RK, Borschel GH, Dennis RG, Brown DL. Myocardial engineering in vivo: formation and characterization of contractile, vascularized three-dimensional cardiac tissue. Tissue Eng. 11(5-6), 803-813 (2005).
21. Zimmermann WH, Melnychenko I, Wasmeier G et al. Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts. Nat. Med. 12(4), 452-458 (2006). •• Large-scale report on implantation of mechanically conditioned hydrogel-based engineered heart tissues that support cardiomyocyte differentiation.
22. Kelm JM, Djonov V, Hoerstrup SP et al. Tissue-transplant fusion and vascularization of myocardial microtissues and macrotissues implanted into chicken embryos and rats. Tissue Eng. 12(9), 2541-2553 (2006). (Pubitemid 46141277)
23. Shimizu T, Yamato M, Isoi Y et al. Fabrication of pulsatile cardiac tissue grafts using a novel 3-dimensional cell sheet manipulation technique and temperatureresponsive cell culture surfaces. Circ. Res. 90(3), e40 (2002). •• Introduces the cell sheet engineering approach to fabricate pulsatile cardiac grafts.
24. Sekine H, Shimizu T, Hobo K et al. Endothelial cell coculture within tissue-engineered cardiomyocyte sheets enhances neovascularization and improves cardiac function of ischemic hearts. Circulation 118(14 Suppl.), S145-S152 (2008).
25. Sekiya S, Shimizu T, Yamato M, Kikuchi A, Okano T. Bioengineered cardiac cell sheet grafts have intrinsic angiogenic potential. Biochem. Biophys. Res. Commun. 341(2), 573-582 (2006). (Pubitemid 43152142)
26. Shimizu T, Sekine H, Isoi Y, Yamato M, Kikuchi A, Okano T. Long-term survival and growth of pulsatile myocardial tissue grafts engineered by the layering of cardiomyocyte sheets. Tissue Eng. 12(3), 499-507 (2006). (Pubitemid 43673455)
27. Shimizu T, Sekine H, Yang J et al. Polysurgery of cell sheet grafts overcomes diffusion limits to produce thick, vascularized myocardial tissues. FASEB J. 20(6), 708-710 (2006). (Pubitemid 46671189)
28. Leor J, Aboulafia-Etzion S, Dar A et al. Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102(19 Suppl. 3), III56-III61 (2000). • In this in vivo study, graft implantation induced neovascularization and improvement of heart function in spite of little donor cell survival and lack of engraftment with host myocardium. Proangiogenic paracrine effects are discussed as the source of heart function improvement.
29. Piao H, Kwon JS, Piao S et al. Effects of cardiac patches engineered with bone marrow-derived mononuclear cells and PGCL scaffolds in a rat myocardial infarction model. Biomaterials 28(4), 641-649 (2007). (Pubitemid 44647449)
30. Kellar RS, Landeen LK, Shepherd BR, Naughton GK, Ratcliffe A, Williams SK. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation 104(17), 2063-2068 (2001). (Pubitemid 33027047)
31. Simpson D, Liu H, Fan TH, Nerem R, Dudley SC Jr. A tissue engineering approach to progenitor cell delivery results in significant cell engraftment and improved myocardial remodeling. Stem Cells 25(9), 2350-2357 (2007). (Pubitemid 47480494)
32. Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 410(6829), 701-705 (2001). (Pubitemid 32290358)
33. Balsam LB, Wagers AJ, Christensen JL, Kofidis T, Weissman IL, Robbins RC. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428(6983), 668-673 (2004). (Pubitemid 38524811)
34. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428(6983), 664-668 (2004). (Pubitemid 38524810)
35. Naito H, Melnychenko I, Didie M et al. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle. Circulation 114(1 Suppl.), I72-I78 (2006). (Pubitemid 44297132)
36. Miyahara Y, Nagaya N, Kataoka M et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction. Nat. Med. 12(4), 459-465 (2006).
37. Bartosh TJ, Wang Z, Rosales AA, Dimitrijevich SD, Roque RS. 3D-model of adult cardiac stem cells promotes cardiac differentiation and resistance to oxidative stress. J. Cell. Biochem. 105(2), 612-623 (2008).
38. Kelm JM, Fussenegger M. Microscale tissue engineering using gravity-enforced cell assembly. Trends Biotechnol. 22(4), 195-202 (2004). • Describes initial experience with in vitro 3D multicellular tissue generation using a gravity-enforced technique.
39. Tan MY, Zhi W, Wei RQ et al. Repair of infarcted myocardium using mesenchymal stem cell seeded small intestinal submucosa in rabbits. Biomaterials 30(19), 3234-3240 (2009).
40. Wei HJ, Chen CH, Lee WY et al. Bioengineered cardiac patch constructed from multilayered mesenchymal stem cells for myocardial repair. Biomaterials 29(26), 3547-3556 (2008).
41. Chen CH, Wei HJ, Lin WW et al. Porous tissue grafts sandwiched with multilayered mesenchymal stromal cell sheets induce tissue regeneration for cardiac repair. Cardiovasc. Res. 80(1), 88-95 (2008).
42. Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat. Med. 14(2), 213-221 (2008). •• Reports decellularization and recellularization of whole rat hearts.
43. O'Shaughnessy L. Surgical treatment of cardiac ischemia. Lancet 232, 185-194 (1937).
44. Ueyama K, Bing G, Tabata Y et al. Development of biologic coronary artery bypass grafting in a rabbit model: revival of a classic concept with modern biotechnology. J. Thorac. Cardiovasc. Surg. 127(6), 1608-1615 (2004). (Pubitemid 38725438)
45. Shao ZQ, Kawasuji M, Takaji K, Katayama Y, Matsukawa M. Therapeutic angiogenesis with autologous hepatic tissue implantation and omental wrapping. Circ. J. 72(11), 1894-1899 (2008).
46. Birla RK, Dhawan V, Dow DE, Huang YC, Brown DL. Cardiac cells implanted into a cylindrical, vascularized chamber in vivo: pressure generation and morphology. Biotechnol. Lett. 31(2), 191-201 (2009).
47. Morritt AN, Bortolotto SK, Dilley RJ et al. Cardiac tissue engineering in an in vivo vascularized chamber. Circulation 115(3), 353-360 (2007).
48. Hoffman RM. To do tissue culture in two or three dimensions? That is the question. Stem Cells 11(2), 105-111 (1993).
49. Eschenhagen T, Fink C, Remmers U et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB J. 11(8), 683-694 (1997). (Pubitemid 27318285)
50. Freed LE, Vunjak-Novakovic G. Microgravity tissue engineering. In Vitro Cell. Dev. Biol. Anim. 33(5), 381-385 (1997).
51. Hoerstrup SP, Zund G, Schnell AM et al. Optimized growth conditions for tissue engineering of human cardiovascular structures. Int. J. Artif. Organs 23(12), 817-823 (2000). (Pubitemid 32058534)
52. Zimmermann WH, Schneiderbanger K, Schubert P et al. Tissue engineering of a differentiated cardiac muscle construct. Circ. Res. 90(2), 223-230 (2002). (Pubitemid 34627092)
53. Radisic M, Park H, Gerecht S, Cannizzaro C, Langer R, Vunjak- Novakovic G. Biomimetic approach to cardiac tissue engineering. Philos. Trans. R. Soc. Lond. B Biol. Sci. 362(1484), 1357-1368 (2007). (Pubitemid 47195028)
54. Kofidis T. Alternative cardiac therapies: stem cells and tissue engineering for the heart www.ctsnet.org/sections/newsandviews/ specialreports/article-4.html